Markers and mediators of inflammation in neonatal lung disease
- 1 April 1997
- journal article
- review article
- Published by Wiley in Pediatric Pulmonology
- Vol. 23 (4) , 292-306
- https://doi.org/10.1002/(sici)1099-0496(199704)23:4<292::aid-ppul7>3.0.co;2-o
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Increase in the concentration of transforming growth factor beta-1 in bronchoalveolar lavage fluid before development of chronic lung disease of prematurityThe Journal of Pediatrics, 1996
- Effect of pulse dexamethasone therapy on the incidence and severity of chronic lung disease in the very low birth weight infantThe Journal of Pediatrics, 1995
- Secretory leukocyte protease inhibitor and lung inflammation in developing bronchopulmonary dysplasiaThe Journal of Pediatrics, 1994
- Effect of dexamethasone on protein metabolism in infants with bronchopulmonary dysplasiaThe Journal of Pediatrics, 1994
- Effects of dexamethasone on chemotactic activity and inflammatory mediators in tracheobronchial aspirates of preterm infants at risk for chronic lung diseaseThe Journal of Pediatrics, 1993
- Controlled trial of beclomethasone dipropionate by nebulization in oxygen- and ventilator-dependent infantsThe Journal of Pediatrics, 1993
- Trial of vitamin A supplementation in very low birth weight infants at risk for bronchopulmonary dysplasiaThe Journal of Pediatrics, 1992
- Elevation of fibronectin levels in lung secretions of infants with respiratory distress syndrome and development of bronchopulmonary dysplasiaThe Journal of Pediatrics, 1992
- Role of Ureaplasma urealyticum in bronchopulmonary dysplasiaThe Journal of Pediatrics, 1989
- Prevention of bronchopulmonary dysplasia by administration of bovine superoxide dismutase in preterm infants with respiratory distress syndromeThe Journal of Pediatrics, 1984